Alberto Garaventa
Istituto Giannina Gaslini(IT)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Cancer, Hypoxia, and Metabolism, Lymphoma Diagnosis and Treatment, Cancer therapeutics and mechanisms, Lung Cancer Research Studies
Most-Cited Works
- → The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report(2008)1,876 cited
- → Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial(2018)383 cited
- → Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial(2017)339 cited
- Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma.(2003)
- → European Intergroup Studies (MMT4-89 and MMT4-91) on Childhood Metastatic Rhabdomyosarcoma: Final Results and Analysis of Prognostic Factors(2004)178 cited
- → Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients(2009)170 cited